Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
azadi ka amrit mahotsav

NIPER Hajipur Signs MoU with IPC to Strengthen Pharmaceutical Standards and Patient Safety


Collaboration to Boost Regulatory Science, Research, and Capacity Building

Posted On: 24 APR 2026 3:17PM by PIB Delhi

The National Institute of Pharmaceutical Education and Research (NIPER), Hajipur has signed a Memorandum of Understanding (MoU) with the Indian Pharmacopoeia Commission (IPC), Ghaziabad, under the Ministry of Health & Family Welfare, Government of India, to promote collaboration in the areas of pharmaceutical standards, regulatory science, and patient safety, today at Kartavya Bhawan, New Delhi.

The MoU was signed in the presence of Manoj Joshi, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. The collaboration aims to foster cooperation in areas of mutual interest, with a focus on strengthening pharmacopeial standards, enhancing patient safety, and advancing scientific research across pharmaceuticals, medical devices, and related healthcare products.

Speaking on the occasion, Shri Manoj Joshi emphasized that such collaborations between premier academic institutions and national standard-setting bodies are crucial for strengthening India’s regulatory science ecosystem. He highlighted that the initiative will help ensure the availability of safe, effective, and quality-assured healthcare products for citizens.

Under the MoU, NIPER Hajipur and IPC will undertake joint research initiatives in key areas, including impurity profiling and safety correlation of drugs, development and validation of advanced analytical methods, and establishment of quality control protocols. The partnership will also support the development of reference standards for complex biologics, biosimilars, and emerging therapeutic products, including cell and gene therapies, facilitating their inclusion in the Indian Pharmacopoeia.

The MoU further envisages capacity building and training initiatives in specialized domains such as biosimilars, cell and gene therapy, and blood and blood-related products, with the objective of strengthening national capabilities in these critical areas.

Prof. K. Ruckmani, Director, NIPER Hajipur; Dr. Kinny Singh, Deputy Secretary, Department of Pharmaceuticals, Dr. V. Kalaiselvan, Secretary, IPC; along with other senior officials and scientists were present during the signing ceremony.

***

PC/PM


(Release ID: 2255260) Visitor Counter : 430
Read this release in: Urdu , हिन्दी